UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 168

Sortiert nach

The role of intermittent androgen deprivation in prostate cancer

BJU international, 2007-10, Vol.100 (4), p.738-743

2007

Volltextzugriff (PDF)

The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancer

BJU international, 2008-12, Vol.102 (11), p.1531-1538

2008

Volltextzugriff (PDF)

An update on the use of gonadotropin-releasing hormone antagonists in prostate cancer

Therapeutic Advances in Urology, 2011-06, Vol.3 (3), p.127-140

2011

Volltextzugriff (PDF)

Anastomotic Urethroplasty for Posttraumatic Urethral Stricture: Previous Urethral Manipulation Has a Negative Impact on the Final Outcome

The Journal of urology, 2007-04, Vol.177 (4), p.1374-1377

2007

Volltextzugriff (PDF)

Androgen Deprivation Therapy for the Treatment of Prostate Cancer: Consider Both Benefits and Risks

European urology, 2009-01, Vol.55 (1), p.62-75

2009

Volltextzugriff (PDF)

Changes in alkaline phosphatase levels in patients with prostate cancer receiving degarelix or leuprolide: results from a 12‐month, comparative, phase III study

BJU international, 2010-07, Vol.106 (2), p.182-187

2010

Volltextzugriff (PDF)

The Effect of Baseline Testosterone on the Efficacy of Degarelix and Leuprolide: Further Insights From A 12-Month, Comparative, Phase III Study in Prostate Cancer Patients

Urology (Ridgewood, N.J.), 2012-07, Vol.80 (1), p.174-181

2012

Volltextzugriff (PDF)

Global update on defining and treating high‐risk localized prostate cancer with leuprorelin: a European perspective

BJU international, 2007-01, Vol.99 (s1), p.2-5

Boccon‐Gibod, Laurent

2007

Volltextzugriff (PDF)

Adjuvant treatment to surgery

BJU international, 2007-07, Vol.100 (s2), p.40-43

Boccon‐Gibod, Laurent

2007

Volltextzugriff (PDF)

Frequency of renal phosphate leak among patients with calcium nephrolithiasis

Kidney international, 2001-07, Vol.60 (1), p.272-276

2001

Volltextzugriff (PDF)

Extensive analysis of the 7q31 region in human prostate tumors supports TES as the best candidate tumor suppressor gene

International journal of cancer, 2004-09, Vol.111 (5), p.798-804

2004

Volltextzugriff (PDF)

Efficacy and Safety of Low Doses of OnabotulinumtoxinA for the Treatment of Refractory Idiopathic Overactive Bladder: A Multicentre, Double-Blind, Randomised, Placebo-Controlled Dose-Ranging Study

European urology, 2012-03, Vol.61 (3), p.520-529

2012

Volltextzugriff (PDF)

Pathological features of prostate cancer detected on initial and repeat prostate biopsy: Results of the prospective European prostate cancer detection study

The Prostate, 2001-05, Vol.47 (2), p.111-117

2001

Volltextzugriff (PDF)

Additional Analysis of the Secondary End Point of Biochemical Recurrence Rate in a Phase 3 Trial (CS21) Comparing Degarelix 80mg Versus Leuprolide in Prostate Cancer Patients Segmented by Baseline Characteristics

European urology, 2010-05, Vol.57 (5), p.836-842

2010

Volltextzugriff (PDF)

Radical Prostatectomy: Open? Laparoscopic? Robotic?

European urology, 2006-04, Vol.49 (4), p.598-599

Boccon-Gibod, Laurent

2006

Volltextzugriff (PDF)

Rolf Ackermann (1941–2015): European Urologist and Gentleman

European urology, 2015-06, Vol.67 (6), p.1198-1199

Boccon-Gibod, Laurent

2015

Volltextzugriff (PDF)

PROSPECTIVE EVALUATION OF PROSTATE CANCER DETECTED ON BIOPSIES 1, 2, 3 AND 4: WHEN SHOULD WE STOP?

The Journal of urology, 2001-11, Vol.166 (5), p.1679-1683

2001

Volltextzugriff (PDF)

Chemotherapeutic Prevention Studies of Prostate Cancer

The Journal of urology, 2004-02, Vol.171 (2), p.S10-S14

2004

Volltextzugriff (PDF)

Absence of microsatellite instability in transitional cell carcinoma of the bladder

Urology (Ridgewood, N.J.), 2000-02, Vol.55 (2), p.287-291

2000

Volltextzugriff (PDF)

The 20-Core Prostate Biopsy Protocol—A New Gold Standard?

The Journal of urology, 2008-02, Vol.179 (2), p.504-507

2008

Volltextzugriff (PDF)

Is transurethral needle ablation a safe and effective treatment for lower urinary tract symptoms secondary to BPH?

Nature clinical practice urology, 2004-11, Vol.1 (1), p.24-25

Gibod, Laurent Boccon

2004

Volltextzugriff (PDF)

EXTENSIVE BIOPSY PROTOCOL IMPROVES THE DETECTION RATE OF PROSTATE CANCER

The Journal of urology, 2000-08, Vol.164 (2), p.393-396

2000

Volltextzugriff (PDF)

Handling and Pathology Reporting of Radical Prostatectomy Specimens

European urology, 2003-12, Vol.44 (6), p.626-636

2003

Volltextzugriff (PDF)

Molecular therapy is advancing with drugs that target pathways relevant for several cancers. Foreword

BJU international, 2012-10, Vol.110 Suppl 1, p.1-2

Boccon-Gibod, Laurent

2012

Volltextzugriff (PDF)

Foreword

BJU international, 2012-10, Vol.110, p.1-2

Boccon‐Gibod, Laurent

2012

Volltextzugriff (PDF)

1 – 25 von 168

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(94)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The role of intermittent androgen deprivation in prostate cancer

The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancer

An update on the use of gonadotropin-releasing hormone antagonists in prostate cancer

Anastomotic Urethroplasty for Posttraumatic Urethral Stricture: Previous Urethral Manipulation Has a Negative Impact on the Final Outcome

Androgen Deprivation Therapy for the Treatment of Prostate Cancer: Consider Both Benefits and Risks

Changes in alkaline phosphatase levels in patients with prostate cancer receiving degarelix or leuprolide: results from a 12‐month, comparative, phase III study

The Effect of Baseline Testosterone on the Efficacy of Degarelix and Leuprolide: Further Insights From A 12-Month, Comparative, Phase III Study in Prostate Cancer Patients

Global update on defining and treating high‐risk localized prostate cancer with leuprorelin: a European perspective

Adjuvant treatment to surgery

Frequency of renal phosphate leak among patients with calcium nephrolithiasis

Extensive analysis of the 7q31 region in human prostate tumors supports TES as the best candidate tumor suppressor gene

Efficacy and Safety of Low Doses of OnabotulinumtoxinA for the Treatment of Refractory Idiopathic Overactive Bladder: A Multicentre, Double-Blind, Randomised, Placebo-Controlled Dose-Ranging Study

Pathological features of prostate cancer detected on initial and repeat prostate biopsy: Results of the prospective European prostate cancer detection study

Additional Analysis of the Secondary End Point of Biochemical Recurrence Rate in a Phase 3 Trial (CS21) Comparing Degarelix 80mg Versus Leuprolide in Prostate Cancer Patients Segmented by Baseline Characteristics

Radical Prostatectomy: Open? Laparoscopic? Robotic?

Rolf Ackermann (1941–2015): European Urologist and Gentleman

PROSPECTIVE EVALUATION OF PROSTATE CANCER DETECTED ON BIOPSIES 1, 2, 3 AND 4: WHEN SHOULD WE STOP?

Chemotherapeutic Prevention Studies of Prostate Cancer

Absence of microsatellite instability in transitional cell carcinoma of the bladder

The 20-Core Prostate Biopsy Protocol—A New Gold Standard?

Is transurethral needle ablation a safe and effective treatment for lower urinary tract symptoms secondary to BPH?

EXTENSIVE BIOPSY PROTOCOL IMPROVES THE DETECTION RATE OF PROSTATE CANCER

Handling and Pathology Reporting of Radical Prostatectomy Specimens

Molecular therapy is advancing with drugs that target pathways relevant for several cancers. Foreword

Foreword

Suchergebnisse filtern